While OpenAI’s lobbying spending is still dwarfed by bigger tech players, the uptick comes as it and other AI companies are ...

To deliver value from generative AI, businesses must take concrete steps to ensure responsible AI becomes part of the ...

AI competition is not a zero-sum game. Instead, the world’s superpowers need to work together to make sure AI benefits ...

Peering into the body to find and diagnose cancer is all about spotting patterns. Radiologists use x-rays and magnetic ...

Ammonia, used in fertilizer, is essential to our lives. Addis Energy is trying to make the chemical underground.

So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...

The company is making a foray into scientific discovery with an AI built to help manufacture stem cells. When you think of AI’s contributions to science, you probably think of AlphaFold, the ...

It’s not always easy to choose whether to store, donate or discard extra IVF embryos. This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter.

Reopening old nuclear plants can only go so far. This article is from The Spark, MIT Technology Review’s weekly climate newsletter. To receive it in your inbox every Wednesday, sign up here.

If we don’t act soon, our online world will continue to be run at the whim of capricious billionaires. Last week, when Mark Zuckerberg announced that Meta would be ending third-party fact ...

More volunteers will get Elon Musk’s brain implant, but don’t expect a product soon. MIT Technology Review’s What’s Next series looks across industries, trends, and technologies to give ...